U of T, McMaster and Genesys Capital Launch Early-Stage Life Sciences Fund A major new venture capital initiative is set to strengthen Ontario’s life sciences ecosystem by providing early-stage funding…
Agilent Expands Altura HPLC Portfolio with New SEC and PLRP-S Columns to Advance Biopharmaceutical Analysis Agilent Technologies Inc. has expanded its Altura high-performance liquid chromatography (HPLC) column portfolio with the…
Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director to Advance Personalized Cancer Immunotherapy Immunocine Cancer Center has announced the appointment of Vita S. Salsman as its new Executive…
Spear Bio to Showcase Next-Generation Alzheimer’s Biomarker Technologies and Automated SPEAR Platform at AAIC 2026 Spear Bio, a biotechnology company specializing in ultrasensitive protein biomarker detection technologies, has announced that…
Agenus Reports Three-Year Phase 1b Results for Botensilimab Plus Balstilimab Showing Durable Survival in Refractory MSS Metastatic Colorectal Cancer Agenus Inc., a biotechnology company focused on advancing next-generation immuno-oncology therapies,…
Bayer Forms Strategic Clinical Trials Alliance with University of Colorado Anschutz, UCHealth, and Children’s Hospital Colorado to Accelerate Medical Innovation Bayer has announced the formation of a landmark strategic alliance…
Paradromics Strengthens Clinical Leadership with Appointment of Dr. William J. Marks Jr. as Chief Clinical Officer Paradromics Inc., a clinical-stage neurotechnology company developing high-bandwidth brain-computer interface (BCI) systems, has announced…
Catalent and Nanoscope Therapeutics Expand Partnership to Advance Commercial Readiness of Vision-Restoring Gene Therapy MCO-010 Catalent, Inc., a global leader in development, manufacturing, packaging, and supply solutions for the pharmaceutical…
LTZ Therapeutics Receives FDA Clearance to Begin Clinical Evaluation of LTZ-232 for Advanced Metastatic Colorectal Cancer and Other Solid Tumors LTZ Therapeutics, a clinical-stage biotechnology company focused on developing next-generation…
bioAffinity Technologies Reports More Than 200% Growth in CyPath® Lung Sales as Physician Adoption Continues to Accelerate bioAffinity Technologies, Inc., a biotechnology company dedicated to developing innovative, noninvasive diagnostic solutions…
Uniquity Bio Strengthens Executive Leadership with Appointment of Matthew Hartzell as Chief Financial Officer Uniquity Bio, a clinical-stage biotechnology company dedicated to developing innovative therapies for immune-mediated and inflammatory diseases,…
Turn Therapeutics Finalizes Phase 2 Study Design for GX-03 Following Positive Interim Analysis in Atopic Dermatitis Turn Therapeutics, Inc., a clinical-stage biotechnology company focused on developing targeted, non-systemic therapies for…